Tags |
|
|
Links |
|
|
Digg It - Get Your Performance Appraisal Discussions Off to a Good Start (Part 1)
But a lot of the awkwardness in performance appraisal meetings can be eliminated by following some simple suggestions. Here are a couple of tips that will help put both players at ease. (In Part 2 of this article, I’ll provide some additional suggestio
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ns.)
Gather Your Appraisal Information and Materials in Advance
The most important item you need to have is a copy of the individual’s performance appraisal. That’s obvious. But that’s not all. At the beginning of the year you and the individual pro
Gather Your Appraisal Information and Materials in Advance
The most important item you need to have is a copy of the individual’s performance appraisal. That’s obvious. But that’s not all. At the beginning of the year you and the individual pro
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ably had a performance planning meeting. Ideally, the individual would have taken notes on a blank copy of the appraisal form and made a copy for you. That document should have all of the key items that you discussed during the meeting. Be sure you hav
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
e a copy of that planning document in case a question about the original goals comes up.
You’ll also need information about the individual’s performance, particularly if there are some areas where the performance varied significantly from your expecta
You’ll also need information about the individual’s performance, particularly if there are some areas where the performance varied significantly from your expecta
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ions. Whether the variation was in a positive or negative direction, you’ll need to be able to demonstrate why you assigned the rating that you did. If the assessment is that the individual’s performance was less than you desired, then it’s critically
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
important that you have all of the evidence you used in order to come to that “Unsatisfactory” or “Need Improvement” performance appraisal rating. There’s a magic phrase to use here. That phrase is, “For example . . .” Make sure you’ve got plenty of ex
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
mples that support a less-than-satisfactory evaluation.
You may want to have a copy of the individual’s development plan. You may want to have copies of weekly reports that the individual submitted that described progress against the goals that were s
You may want to have a copy of the individual’s development plan. You may want to have copies of weekly reports that the individual submitted that described progress against the goals that were s
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
et. You can’t make a mistake by having too much support material. It will prevent the embarrassment of being unable to find anything of substance to justify the rating you gave.
Make a List
What are the key points that you want to cover during
Make a List
What are the key points that you want to cover during
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
the discussion? In addition to having a copy of the performance appraisal, write down a list of the most important items you want to discuss. It’s easy to refer to them during the meeting to make sure that everything that needs to be discussed gets cov
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ered.
Pick an Appropriate Place
Probably most performance appraisal discussions take place in the manager’s office, with the manager behind the desk and the appraisee sitting directly in front of it.
Is that the best place to hold the discuss
Pick an Appropriate Place
Probably most performance appraisal discussions take place in the manager’s office, with the manager behind the desk and the appraisee sitting directly in front of it.
Is that the best place to hold the discuss
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
on? It may well be, particularly if the performance appraisal is not very good and the manager wants to trot out all of the power and authority available to make the subordinate understand that immediate change is necessary. But too often the authorita
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
rian, boss-behind-the-desk arrangement serves to emphasize the power relationship at a time when a more collegial approach might be more effective.
More important than the actual location where the discussion ends up taking place is the decision-makin
More important than the actual location where the discussion ends up taking place is the decision-makin
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
process the manager engages in to determine that location. Too often, managers conduct the performance appraisal discussion behind their desks by default — they haven’t given any thought to the matter and just let it happen in the place where they are
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
most comfortable.
There are several other alternatives possible. The manager’s office might not offer complete privacy, particularly if walls are thin or it’s a cubicle arrangement. In this case a conference room or the temporarily vacant office of a
There are several other alternatives possible. The manager’s office might not offer complete privacy, particularly if walls are thin or it’s a cubicle arrangement. In this case a conference room or the temporarily vacant office of a
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
out-of town senior manager might be pressed into service. If the performance appraisal contains good news and the two participants in the appraisal drama are old colleagues, it might best be conducted over a cup of coffee in the cafeteria. And if it i
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s conducted in the manager’s office, just a little furniture rearrangement might reduce the hierarchical nature of the discussion.
If the performance appraisal does indeed contain bad news, and particularly if the manager believes that it will take a
If the performance appraisal does indeed contain bad news, and particularly if the manager believes that it will take a
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ramatic gesture to bring home the message of “Change or else!”, the appraiser’s boss’s office might be a good location. Having your boss give you your performance appraisal in her boss’s office — with her boss sitting in as an observer / reinforcer — c
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ertainly communicates the seriousness of the message being delivered.
But beware the unusual location. The district sales manager who gives one of her sales reps his annual performance appraisal while the two of them are in the car, driving down the h
But beware the unusual location. The district sales manager who gives one of her sales reps his annual performance appraisal while the two of them are in the car, driving down the h
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ghway on route to a new prospect’s office, is exercising bad judgment. So too is any manager who selects a location significantly away from a business setting, unless the necessity for conducting the performance review at that time, in that location, i
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s obvious to both players.
These are some small suggestions that will help to reduce the awkwardness that always seems to surround the performance appraisal discussion. In Part 2, I’ll provide a couple more tips that will help put both players at ease
These are some small suggestions that will help to reduce the awkwardness that always seems to surround the performance appraisal discussion. In Part 2, I’ll provide a couple more tips that will help put both players at ease
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/23071/diggit-Get-Your-Performance-Appraisal-Discussions-Off-to-a-Good-Start-Part-1.html">Get Your Performance Appraisal Discussions Off to a Good Start (Part 1)</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/23071/diggit-Get-Your-Performance-Appraisal-Discussions-Off-to-a-Good-Start-Part-1.html]Get Your Performance Appraisal Discussions Off to a Good Start (Part 1)[/url]
Related Articles:
Fuel Costs Skyrocket Does This Hurt Companies Who Pass On the Costs Also?
Does The Employee Have What It Takes To Be The Owner?
Bookmark it:
|